CRXT

Clarus Therapeutics (CRXT)

Clarus Therapeutics Holdings Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:CRXT

1 2 3 4 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2023/03/07	20:05	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2023/03/01	21:36	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2023/03/01	21:23	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2023/03/01	21:20	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2023/03/01	21:17	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2023/03/01	21:07	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2023/02/23	06:19	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2023/01/25	06:02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/12/23	06:24	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/11/23	20:11	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/10/19	05:05	GlobeNewswire Inc.	Clarus Therapeutics Holdings, Inc. Announces Completion of Auction for Sale of JATENZO® and Selection of Tolmar, Inc. as Successful Bidder	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/09/14	22:52	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/09/06	11:19	GlobeNewswire Inc.	Clarus Therapeutics Holdings, Inc. Announces Plan for Near-Term Sale of JATENZO® Using Structured Process Through Chapter 11 of the U.S. Bankruptcy Code	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/08/27	05:37	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/08/27	05:33	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/08/27	05:30	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/08/27	05:19	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/08/23	01:05	TipRanks	Clarus Therapeutics Holdings (CRXT) was downgraded to a Hold Rating at Needham	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/08/19	19:38	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/08/19	19:34	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/08/19	19:32	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/08/19	19:13	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/08/19	05:50	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/08/19	05:14	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/08/19	05:05	GlobeNewswire Inc.	Clarus Therapeutics Reports Second Quarter 2022 Financial and Operating Results and Announces Workforce Reduction	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/08/10	19:06	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/08/10	19:05	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/08/10	06:25	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/07/28	22:05	GlobeNewswire Inc.	Clarus Therapeutics Announces Notice of Allowance for Additional Patent Claims Covering JATENZO® (testosterone undecanoate)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc
2022/07/07	05:00	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:CRXT	Clarus Therapeutics Holdings Inc